Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease
about
Salivary microbiota and metabolome associated with celiac diseaseDiagnosing gastrointestinal illnesses using fecal headspace volatile organic compoundsCloning, expression and characterization of a β-D-xylosidase from Lactobacillus rossiae DSM 15814(T)Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN).Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infantsLactobacillus rossiae, a vitamin B12 producer, represents a metabolically versatile species within the Genus LactobacillusFecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specifiedIntestinal microbiota and probiotics in celiac diseaseThe influence of a short-term gluten-free diet on the human gut microbiome.Plaque-left-behind after brushing: intra-oral reservoir for antibacterial toothpaste ingredients.US perspective on gluten-related diseases.Nanoscale Sensor Technologies for Disease Detection via Volatolomics.Gut Microbiota and Celiac Disease.The effects of oats on the function of gut microflora in children with coeliac disease.In vivo biofilm formation on stainless steel bonded retainers during different oral health-care regimensInvestigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.An In Vitro Fermentation Study on the Effects of Gluten FriendlyTM Bread on Microbiota and Short Chain Fatty Acids of Fecal Samples from Healthy and Celiac Subjects.Hydroxycinnamic acids used as external acceptors of electrons: an energetic advantage for strictly heterofermentative lactic acid bacteriaDraft genome sequence of Lactobacillus rossiae DSM 15814(T).Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly.Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.EFFECTS OF PROBIOTIC INTAKE ON INTESTINAL BIFIDOBACTERIA OF CELIAC PATIENTS.Biofilm formation on stainless steel and gold wires for bonded retainers in vitro and in vivo and their susceptibility to oral antimicrobials.Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet.Metabolomics toward personalized medicine.Design of Primers for Evaluation of Lactic Acid Bacteria Populations in Complex Biological SamplesA low-gluten diet induces changes in the intestinal microbiome of healthy Danish adultsCross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity
P2860
Q24756993-3CBFB7E4-7705-4312-92CD-D236D37B0FDBQ26773205-01A0B9DB-DC56-42AA-8218-BA66990E1D4EQ28833604-4E232012-EC77-4748-BF8A-438ADA791237Q33748498-E6CAD4C8-05EB-4EF1-A5E8-A2DF3165AF08Q34021561-CD47DCA9-3461-4E81-9815-455ADAAA9643Q34039831-02F1638C-D5B5-444E-B17A-58EC1BD6B44DQ34202899-B0DB1B4E-70EB-437B-8B10-1A25F50B8C2AQ34440834-6222058E-CE57-4FDC-87A3-F490E54B4C49Q35018672-D94D7452-1920-442F-89B6-42C949655549Q35198926-4DA7B1CD-844F-457F-BCCB-78AD1CF9E6DDQ35996496-6DB29A55-F4B6-4F75-AEC4-2E3E0415E95AQ36236865-51E7046E-CD1B-4584-A992-80D5DF49E5ACQ37538105-B4DB693A-1A70-422D-9E8E-6CC74888C2FBQ38602462-6DD9A126-6528-47DE-8CBB-DE8E5438F771Q38685400-358A330E-4DC2-45CC-874A-0458DC7D01BEQ39224479-F7E789F0-6CE3-48DC-9709-E50441B5D543Q39780572-F593F087-7176-438F-B5BD-4005096B535FQ40066779-B7B302F5-42EA-49B7-9972-55EAECF46EA5Q41312547-61CDF6F6-2A63-4CDC-ABE6-367FB10196D6Q42248613-E05CE119-4D81-4E80-95A9-DE9ACB2C0292Q42700385-6A390F63-E34E-437D-90E4-EED2002C7C16Q43828336-DB951664-8CD2-4452-8F91-5B465D63E568Q45573898-3F25B817-9457-4065-B4E1-79520EE285A2Q46407305-8ADBF280-78D2-4B35-9BA8-AC7EEC537800Q46677678-F2BCD517-C294-4145-93ED-CECD874FC2E7Q46869172-72B5C5A4-4CB8-4B6B-8BD4-F86BEF906C54Q50090010-39595E03-77CF-4AD8-9FA4-0CD3D1F0D3B4Q58780982-D8CA176C-4C84-4D4E-A592-549A9A3DBAB1Q59132684-101AB630-B58C-486E-9435-1BB2BFC5CADFQ59137735-C2C3B073-0800-47D5-B8A3-0A9220F4764C
P2860
Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Different fecal microbiotas an ...... d children with celiac disease
@ast
Different fecal microbiotas an ...... d children with celiac disease
@en
type
label
Different fecal microbiotas an ...... d children with celiac disease
@ast
Different fecal microbiotas an ...... d children with celiac disease
@en
prefLabel
Different fecal microbiotas an ...... d children with celiac disease
@ast
Different fecal microbiotas an ...... d children with celiac disease
@en
P2093
P2860
P50
P356
P1476
Different fecal microbiotas an ...... d children with celiac disease
@en
P2093
Francesca Gagliardi
M Elisabetta Guerzoni
Maurice Ndagijimana
P2860
P304
P356
10.1128/AEM.02793-08
P407
P50
P577
2009-04-17T00:00:00Z